SEC Form 4 · accession 0001209191-16-139554
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis Willard Sarena
Officer — EVP, Gen Counsel and Secretary
Period of report
Sep 1, 2016
Accepted (ET)
Sep 1, 2016 · 7:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | F | 19,568 | $44.74 | D | 74,266 | D |
Table II — derivative securities
No Table II lines on this filing.